Uso de Antidepresivos e Ideación Suicida en Jóvenes con Síndrome de Ovario Poliquístico: Revisión Sistemática
DOI:
https://doi.org/10.36489/saudecoletiva.2025v16i101p17314-17333Palabras clave:
Antidepresivos, Ideación Suicida, Síndrome del Ovario PoliquísticoResumen
Objetivo: Investigar la relación entre el uso de antidepresivos y el aumento del riesgo de ideación suicida en adolescentes con síndrome de ovario poliquístico (SOP). Método: Revisión sistemática de la literatura según el protocolo PRISMA. Resultados: Se incluyeron veinticuatro artículos que destacan una alta prevalencia de depresión y ansiedad en mujeres con SOP, especialmente adolescentes. La evidencia sugiere que algunos antidepresivos, debido a sus efectos ansiogénicos, pueden aumentar el riesgo de ideación suicida, lo cual es especialmente preocupante en este grupo, que ya tiene un riesgo de suicidio hasta ocho veces mayor. Conclusión: La selección de antidepresivos debe ser juiciosa, considerando los riesgos específicos de cada clase de fármaco. Las intervenciones no farmacológicas, como la terapia cognitivo-conductual, han demostrado eficacia en la reducción de la fatiga y la mejora de la calidad de vida, lo que refuerza la importancia de los enfoques terapéuticos combinados.
Citas
Hsu TW, Kao YC, Tsai SJ, Bai YM, Su TP, Chen TJ, et al. Suicide Attempts After a Diagnosis of Polycystic Ovary Syndrome. Annals of Internal Medicine. 2024 Feb 6. https://doi.org/10.7326/m23-2240
Khan AYR, Abdullah MA, Gul R, Bhutta HR, Imran M, Mazhar SB, et al. Prevalence of Anxiety and Depression Among Women With Polycystic Ovarian Syndrome: A Cross-Sectional Study From a Tertiary Care Hospital of Islamabad, Pakistan. Cureus. 2024 Jan 19. https://doi.org/10.7759/cureus.52540
Wright PA, Tavakoli AS, Corbett CF. PCOS health-related quality-of-life and depressive symptoms across the lifespan: Comparative study. Journal of Women & Aging. 2023 Jul 5;36(1):1–16. https://doi.org/10.1080/08952841.2023.2230112
Hetrick SE, McKenzie JE, Bailey AP, Sharma V, Moller CI, Badcock PB, et al. New generation antidepressants for depression in children and adolescents: a network meta-analysis. Cochrane Database of Systematic Reviews. 2021 May 24;2021(5). https://doi.org/10.1002/14651858.cd013674.pub2
Page MJ, McKenzie JE, Bossuyt PM, et al. A declaração PRISMA 2020: diretriz atualizada para relatar revisões sistemáticas. Rev Panam Salud Publica 2022; 46: e112. https://doi.org/10.26633/RPSP.2022.112
Souza TM, Silva MD, Carvalho R. Revisão integrativa: o que é e como fazer. Einstein. 2010;8(1):102–8. https://doi.org/10.1590/S1679-45082010RW1134
Galvão TF, Pereira MG. Revisões sistemáticas da literatura: passos para sua elaboração. Epidemiologia e Serviços de Saúde. 2014;23(1):183–4. http://dx.doi.org/10.5123/S1679-49742014000100018
Fitz V, Graca S, Mahalingaiah S, Liu J, Lai L, Butt A, et al. Inositol for Polycystic Ovary Syndrome: a systematic review and meta-analysis to inform the 2023 update of the International Evidence-Based PCOS Guidelines. The Journal of Clinical Endocrinology and Metabolism. 2024 Nov 18;109(12):e2365. https://doi.org/10.1210/clinem/dgad762
Juhász AE, Stubnya MP, Teutsch B, et al. Ranking the dietary interventions by their effectiveness in the management of polycystic ovary syndrome: a systematic review and network meta-analysis. Reprod Health. 2024;21(1):28. https://doi.org/10.1186/s12978-024-01758-5
Melin J, Forslund M, Alesi S, et al. Metformin and Combined Oral Contraceptive Pills in the Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis. J Clin Endocrinol Metab. 2024;109(2):e817-e836. https://doi.org/10.1210/clinem/dgad465
Goldberg A, Graca S, Liu J, et al. Anti-obesity pharmacological agents for polycystic ovary syndrome: A systematic review and meta-analysis to inform the 2023 international evidence-based guideline. Obes Rev. 2024;25(5):e13704. https://doi.org/10.1111/obr.13704
Gomaa MA, Desoky AA, Amer D, Alaa D, Khalil MA. Impulsividade, depressão e suicídio em pacientes do sexo feminino com síndrome dos ovários policísticos e infertilidade. Middle East Current Psychiatry 2023 Dec 12;30(1). https://mecp.springeropen.com/articles/10.1186/s43045-023-00386-2
Abdollahi L, Mirghafourvand M, Babapour JK, Mohammadi M. Effectiveness of cognitive-behavioral therapy (CBT) in improving the quality of life and psychological fatigue in women with polycystic ovarian syndrome: a randomized controlled clinical trial. Journal of Psychosomatic Obstetrics & Gynecology. 2018 Sep 3;40(4):283–93. https://doi.org/10.1080/0167482x.2018.1502265
Dewani D, Karwade P, Mahajan KS. The Invisible Struggle: The Psychosocial Aspects of Polycystic Ovary Syndrome. Cureus. 2023 Dec 30;15(12):e51321. https://doi.org/10.7759/cureus.51321
Brutocao C, Zaiem F, Alsawas M., Morrow AS, Murad MH, Javed A. Transtornos psiquiátricos em mulheres com síndrome dos ovários policísticos: uma revisão sistemática e meta-análise. Endócrino. 2018;62:318–325. https://doi.org/10.1007/s12020-018-1692-3
Standeven LR, Olson E, Leistikow N, Payne JL, Osborne LM, Hantsoo L. Polycystic Ovary Syndrome, Affective Symptoms, and Neuroactive Steroids: a Focus on Allopregnanolone. Current Psychiatry Reports. 2021 Apr 21;23(6). https://doi.org/10.1007/s11920-021-01244-w
National Institute for Health an Care Excellence (NICE). Depression in Children and Young people: Identification and Management. NICE guideline [Internet]. 2019 2 Jun. Available from: https://www.nice.org.uk/guidance/ng134
Valença RCP, Guimarães SB, Siqueira L da P. Prescrição e uso de antidepressivos em crianças e adolescentes – uma revisão da literatura. Brazilian Journal of Development. 2020;6(12):94860–75. https://doi.org/10.34117/bjdv6n12-101
Piccini CD, Michelon ES, Medeiros AG, Heinen CA, Maranghelli GS, Eye HV. Síndrome dos policistos, complicações metabólicas, cardiovasculares, psíquicas e neoplásicas a longo prazo: uma revisão sistemática. Clin Biomed Res 2020: 40(3):184-192. https://seer.ufrgs.br/index.php/hcpa/article/view/10769
Cooney LG, Lee I, Sammel MD, Dokras A. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2017;32(5):1075-1091. https://doi.org/10.1093/humrep/dex044
Tavares RS, Gonçalves BR, Amaral WN do, Francescantônio ICM, Júnior EEG, Danziger LR, et al. Prevalência de transtornos mentais em mulheres com síndrome do ovário policístico - revisão sistemática. Revista Eletrônica Acervo Saúde, 3 Fev. 2019;11(6):e250. https://doi.org/10.1590/1981-5271v43suplemento1-20180260
Majidzadeh S, Mirghafourvand M, Farvareshi M, Yavarikia P. The effect of cognitive behavioral therapy on depression and anxiety of women with polycystic ovary syndrome: a randomized controlled trial. BMC psychiatry. 2023 May 1123(1):332. https://doi.org/10.1186/s12888-023-04814-9
Gonçalves GC, Moreira FP, Fonseca IF, Borges GD, de Siqueira EC. Impacto das mudanças de estilo de vida na Síndrome do Ovário Policístico – uma revisão integrativa. Braz. J. Hea. Rev. 2024 Feb 14;7(1):5520–33. https://doi.org/10.34119/bjhrv7n1-447
Jiskoot G, Benneheij SH, Beerthuizen A, de Niet JE, de Klerk C, Timman R, et al. A three-component cognitive behavioural lifestyle program for preconceptional weight-loss in women with polycystic ovary syndrome (PCOS): a protocol for a randomized controlled trial. Reproductive Health [Internet]. 2017 Mar 6;14(1). https://doi.org/10.1186/s12978-017-0295-4
Carvalho TR de, Soares JM. Características que envolvem o processo de emagrecimento em mulheres com síndrome dos ovários policísticos (SOP): uma revisão de literatura. RBONE - Revista Brasileira de Obesidade, Nutrição e Emagrecimento. 2022 Aug 31;16(100):192–9. https://www.rbone.com.br/index.php/rbone/article/view/1959
Jiskoot G, Dietz de Loos A, Beerthuizen A, Timman R, Busschbach J, Laven J. Long-term effects of a three-component lifestyle intervention on emotional well-being in women with Polycystic Ovary Syndrome (PCOS): A secondary analysis of a randomized controlled trial. Atkin SL, editor. PLOS ONE. 2020 Jun 1;15(6):e0233876. https://doi.org/10.1371/journal.pone.0233876
Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertility and Sterility. 2018 Aug;110(3):364–79. https://doi.org/10.1016/j.fertnstert.2018.05.004








